Prismic Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Prismic Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11150
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Prismic Pharmaceuticals Inc (Prismic Pharmaceuticals) is a specialty pharmaceutical company that offers development of prescription drugs. The company offers research and development programs for prescription product candidates and provides unique safety profiles. It develops drugs for inflammatory diseases and oxidative stress disorders. Prismic Pharmaceuticals pipeline products are used for the treatment of fibromyalgia and severe chronic pain. Its PP101 is used in the treatment of chronic pain such as pregabalin, duloxetine, gabapentin or analgesics and opiates such as hydrocodone, morphine and oxycodone. Prismic Pharmaceuticals is headquartered in Worcester, Massachusetts, the US.

Prismic Pharmaceuticals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Prismic Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Prismic Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Prismic Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Prismic Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Prismic Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Prismic Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Prismic Pharma Acquires Omega-3 Patents From Scarista 10
Venture Financing 11
Prismic Pharma To Raise US$10 Million In Venture Financing 11
Prismic Pharma Raises US$1.2 Million In Venture Financing 12
Licensing Agreements 13
Prismic Pharma Enters Into Licensing Agreement With Epitech 13
Prismic Pharmaceuticals Inc – Key Competitors 14
Prismic Pharmaceuticals Inc – Key Employees 15
Prismic Pharmaceuticals Inc – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Prismic Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 2
Prismic Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Prismic Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Prismic Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Prismic Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Prismic Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Prismic Pharma Acquires Omega-3 Patents From Scarista 10
Prismic Pharma To Raise US$10 Million In Venture Financing 11
Prismic Pharma Raises US$1.2 Million In Venture Financing 12
Prismic Pharma Enters Into Licensing Agreement With Epitech 13
Prismic Pharmaceuticals Inc, Key Competitors 14
Prismic Pharmaceuticals Inc, Key Employees 15

List of Figures
Prismic Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Prismic Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Prismic Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Prismic Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Prismic Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Prismic Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Prismic Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Prismic Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Prismic Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • California Physicians’ Service:企業の戦略的SWOT分析
    California Physicians' Service - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Telekom Malaysia Bhd (TM):企業の財務・戦略的SWOT分析
    Telekom Malaysia Bhd (TM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • HollyFrontier Corp (HFC):企業の財務・戦略的SWOT分析
    HollyFrontier Corp (HFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Cheniere Energy Inc (LNG):企業の財務・戦略的SWOT分析
    Cheniere Energy Inc (LNG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Navios Maritime Partners L.P.:企業のM&A・事業提携・投資動向
    Navios Maritime Partners L.P. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Navios Maritime Partners L.P. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • CBS Corporation (CBS):企業の財務・戦略的SWOT分析
    CBS Corporation (CBS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Mitsui O.S.K. Lines Ltd (9104)-石油・ガス分野:企業M&A・提携分析
    Summary Mitsui O.S.K. Lines Ltd (MOL) is a global marine logistic company. It owns and operates dry bulkers, tankers, LNG carriers, containerships, ferries & coastal RoRo ships, cruise ships. The company’s dry bulkers transport dry bulk cargo such as iron ore, coal, grains, wood, wood chips, cement, …
  • Vietnam Dairy Products Joint Stock Co:戦略・SWOT・企業財務分析
    Vietnam Dairy Products Joint Stock Co - Strategy, SWOT and Corporate Finance Report Summary Vietnam Dairy Products Joint Stock Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Tokyu Land Corporation:企業の戦略・SWOT・財務情報
    Tokyu Land Corporation - Strategy, SWOT and Corporate Finance Report Summary Tokyu Land Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Natera Inc (NTRA):企業の財務・戦略的SWOT分析
    Summary Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers Panorama, a non-invasive prenatal screening test that analyzes baby's DNA through a simple blood dra …
  • ZIOPHARM Oncology Inc (ZIOP)-製薬・医療分野:企業M&A・提携分析
    Summary Ziopharm Oncology Inc (Ziopharm), formerly EasyWeb Inc is a biotechnology company that discovers and develops cancer therapies. The company develops novel gene expression, control and cell technologies to provides cell-based therapies for the treatment of cancer and graft-versus-host-disease …
  • Olympus Corporation (7733)-医療機器分野:企業M&A・提携分析
    Summary Olympus Corporation (Olympus) is a manufacturer of precision machineries and instruments. The company develops, manufactures and markets equipment and devices for medical, healthcare, imaging, information, and other industrial markets. It offers a wide range of products including digital SLR …
  • MS Amlin plc:企業の戦略的SWOT分析
    MS Amlin plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • LCI Industries:企業の戦略・SWOT・財務分析
    LCI Industries - Strategy, SWOT and Corporate Finance Report Summary LCI Industries - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Cogentix Medical Inc (CGNT):企業の財務・戦略的SWOT分析
    Summary Cogentix Medical Inc (Cogentix Medical), formerly Vision-Sciences Inc, is a medical device company that designs, develops, manufactures and markets fiberoptic and video endoscopy products. The company’s major products include PrimeSight endoscopy systems, Urgent PC neuromodulation system and …
  • Novartis Institutes for BioMedical Research Inc-製薬・医療分野:企業M&A・提携分析
    Summary Novartis Institutes for BioMedical Research Inc (NIBR), a subsidiary of Novartis AG is a medical research institute that offers treatment research and development programs. The institute offers clinical research services in areas of immuno-oncology, oncology, neuroscience, cardiovascular and …
  • W.W. Grainger Inc (GWW):企業の財務・戦略的SWOT分析
    W.W. Grainger Inc (GWW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Meiji Co Ltd:企業の戦略・SWOT・財務分析
    Meiji Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Meiji Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Globus Medical Inc (GMED):企業の財務・戦略的SWOT分析
    Globus Medical Inc (GMED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Nascent Biotech Inc (NBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Nascent Biotech Inc (Nascent) is a clinical-stage biopharmaceutical company. The company delivers human monoclonal antibodies and cytokine for the treatment of cancer and drug discovery platform for identifying new antibodies and antigens for commercialization. It develops Pritumumab, a mono …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆